Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation

Transplantation

Volumn 66, Issue 9, 1998, Pages 1186-1192

  MacPhee, Iain A M ^a,b   Bradley, J Andrew ^b   Briggs, J Douglas ^b   Junor, Brian J R ^b   MacPherson, Stuart G ^b   McMillan, Margaret A ^b   Rodger, R Stuart C ^b   Watson, Mary A ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; OKT 3; PREDNISOLONE; STEROID; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0032533409     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199811150-00013     Document Type: Article

References (38)

1. The Canadian Multicentre Transplant Study Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation: analysis at three years. N Engl J Med 1986; 314: 1219.
2. Calne RY. Cyclosporin in cadaveric renal transplantation: 5-year follow-up of a multi-centre trial. Lancet 1987; 2: 506.
3. Morris PJ, Chapman JR, Allen RD, et al. Cyclosporin conversion versus conventional immunosuppression: long-term follow-up and histological evaluation. Lancet 1987; 1: 586.
4. Fischel RJ, Payne WD, Gillingham KJ, et al. Long-term outlook for renal transplant recipients with one-year function: "Doctor, what are my chances?" Transplantation 1991; 51: 118.
5. Myers BD, Newton L, Oyer P. The case against the indefinite use of cyclosporine. Transplant Proc 1991; 23: 41.
6. Porter GA, Bennett WM, Sheps SG. Cyclosporine-associated hypertension. Arch Intern Med 1990; 150: 280.
7. Land W, Castro LA, Hillebrand G, Gunther K, Gokel JM. Conversion rejection consequences by changing the immunosuppressive therapy from cyclosporine to azathioprine after kidney transplantation. Transplant Proc 1983; 15: 2857.
8. Morris PJ, French ME, Dunnill MS, et al. A controlled trial of cyclosporine in renal transplantation with conversion to azathioprine and prednisolone after three months. Transplantation 1983; 36: 273.
9. Adu D, Michael J, McMaster P. Conversion from cyclosporin to azathioprine/prednisolone. Lancet 1985; 1: 392.
10. Hoitsma AJ, Wetzels JFM, van Lier HJJ, Berden JHM, Koene RAP. Cyclosporin treatment with conversion after three months versus conventional immunosuppression in renal allograft recipients. Lancet 1987; 1: 584.
11. Hall BM, Tiller DJ, Hardie I, et al. Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine. N Engl J Med 1988; 318: 1499.
12. Spielberger M, Aigner F, Schmid T, Bosmuller C, Konigsrainer A, Margreiter R. Long-term results of cadaveric renal transplantation after conversion from cyclosporine to azathioprine: a controlled randomized trial. Transplant Proc 1988; 20: 169.
13. Hollander AAMJ, van Saase JLCM, Kootte AMM, et al. Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Lancet 1995; 345: 610.
14. Sobh MA, Eldein ABS, Moustafa FE, Ghoneim MA. Elective conversion from cyclosporin to azathioprine in living related donor kidney transplants. Nephrol Dial Transplant 1987; 2: 258.
15. Delmonico FL, Conti D, Auchincloss H Jr., et al. Long-term, low-dose cyclosporine treatment of renal allograft recipients: a randomised trial. Transplantation 1990; 49: 899.
16. Hiesse C, Neyrat N, Deglise-Favre A, et al. Randomized prospective trial of elective cyclosporine withdrawal from triple therapy at 6 months after cadaveric renal transplantation. Transplant Proc 1991; 23: 987.
17. Sagalowsky AI, Reisman ME, Dawidson I, Toto R, Peters PC, Helderman JH. Late cyclosporine conversion carries risk of irreversible rejection. Transplant Proc 1988; 20: 157.
18. Sweny P, Lui SF, Scoble JE, Varghese Z, Fernando ON, Moorhead JF. Conversion of stable renal allografts at one year from cyclosporin A to azathioprine: a randomized controlled study. Transplant Int 1990; 3: 19.
19. Pedersen EB, Hansen HE, Kornerup HJ, Madsen S, Sorensen AWS. Long-term graft survival after conversion from cyclosporin to azathioprine 1 year after renal transplantation: a prospective, randomized study from 1 to 6 years after transplantation. Nephrol Dial Transplant 1993; 8: 250.
20. Busing M, Holzer H, Schareck WD, et al. Is long-term therapy without cyclosporin A (CsA) indispensable or dangerous? One-year results of a prospective randomized trial. Transplant Proc 1989; 21: 1601.
21. Isoniemi H. Renal allograft immunosuppression. III. Triple therapy versus three different combinations of double drug treatment: two year results in kidney transplant patients. Transplant Int 1991; 4: 31.
22. Junor BJR, More IAR, Bradley JA, et al. Histological changes in renal allografts after successful conversion from cyclosporin A to azathioprine. Transplant Proc 1989; 21: 1677.
23. Watson MA, Briggs JD, Junor BJR, et al. Randomised trial of conversion from cyclosporin to azathioprine at one year after renal transplantation. Transplant Proc 1989; 21: 1583.
24. Rowe PA, Watson MA, McMillan MA, Briggs JD, Rodger RSC, Junor BJR. Prospective randomised study of the influence of cyclosporin on long-term renal allograft function. Transplant Proc 1994; 26: 2617.
25. Kasiske BL, Heim-Duthoy K, Ma JZ. Elective cyclosporine withdrawal after renal transplantation: a meta-analysis. JAMA 1993; 269: 395.
26. Rocher LL, Milford EL, Kirkman RL, Carpenter CB, Strom TB, Tilney NL. Conversion from cyclosporine to azathioprine in renal allograft recipients. Transplantation 1984; 38: 669.
27. Chapman JR, Morris PJ. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine. Transplant Proc 1985; 17 (Suppl. 1): 254.
28. Versluis DJ, Wenting GJ, Derkx FHM, Schalekamp MADH, Jeekel J, Weimar W. Who should be converted from cyclosporine to conventional immunosuppression in kidney transplantation, and why. Transplantation 1987; 44: 387.
29. Opelz G. Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome. Transplantation 1994; 58: 443.
30. Harris KPG, Russell GI, Parvin SD, Veitch PS, Walls, J. Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients. Br Med J 1986; 292: 16.
31. Mittal R, Agrawal SK, Dash SC, et al. Clinical profile and course and outcome of late acute rejection episodes in living-related-donor renal allograft recipients. Nephron 1995; 71: 40.
32. Dunn J, Golden D, Van Buren CT, Lewis RM, Lawen J, Kahan, BD. Causes of graft loss beyond two years in the cyclosporine era. Transplantation 1990; 49: 349.
33. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
34. Shen SY, Weir MR, Coughlin TR. Renal allograft biopsy and conversion of cyclosporine to azathioprine. Transplantation 1989; 47: 223.
35. Gonwa TA, Atkins C, Velez RL, et al. Metabolic consequences of cyclosporine-to-azathioprine conversion in renal transplantation. Clin Transplant 1988; 2: 91.
36. Tegzess AM, van Son WJ, de Maar EF, Beelen JM, Sluiter WJ, Huisman RM. Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function. Transplant Proc 1989; 21: 1635.
37. Pedersen EB, Hansen HE, Olsen S, et al. Comparison between the effects of cyclosporine and azathioprine on functional and morphologic renal parameters in a randomized study from 12 to 24 months after renal transplantation. Clin Transplant 1991; 5: 456.
38. Ratcliffe PJ, Dudley CRK, Higgins RM, Firth JD, Smith B, Morris PJ. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 1996; 348: 643.